Results 131 to 140 of about 153,444 (192)

Cost-per-remitter for esketamine nasal spray versus quetiapine for treatment-resistant depression. [PDF]

J Comp Eff Res
Clemens K, Teeple A, Rive B, Kirson N, Desai U, Doran J, Eid D, Qu A, Bowrey H, Joshi K.   +9 more
europepmc   +1 more source

Antidepressant-like activity of Bezafibrate in mice models of depression: a behavioral and neurobiological characterization. [PDF]

Front Pharmacol
Xu D, Zhou J, Zhou S, Wang W, Wang C, Jiang B, Zhao W.   +6 more
europepmc   +1 more source

Unveiling the Anti-Inflammatory Effects of Antidepressants: A Systematic Review of Human Studies over the Last Decade. [PDF]

Pharmaceuticals (Basel)
Bleibel L, Sokołowska P, Henrykowska G, Owczarek J, Wiktorowska-Owczarek A.   +4 more
europepmc   +1 more source

Pharmacotherapy of psychiatric inpatients with mental and behavioral disorders caused by sedatives or hypnotics (F13): Results from an observational pharmacovigilance program between 2000 and 2017. [PDF]

Addict Sci Clin Pract
Pauwels P, Haack B, Toto S, Seifert J, Grohmann R, Heinze M, Zolk O, Proskynitopoulos PJ, Schneider M, Greiner T.   +9 more
europepmc   +1 more source

Serum Pharmacology Combined with Network Pharmacology Reveals the Effects and Mechanisms of Ganmai Dazao Decoction in the Treatment of Depression. [PDF]

ACS Omega
Wei B, Zheng J, Yan X, Zuo T, Xu Y, Hong M.   +5 more
europepmc   +1 more source

Fixed dose combination dextromethorphan-bupropion: A hope for treatment resistant depression (TRD).

Indian J Psychiatry
Das R, Chakravarty R, Gantait VV, Bhattacharjee S.   +3 more
europepmc   +1 more source